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Background: We compared the attention abilities of a group of first-episode schizophrenia (FES) patients and a
group of healthy participants using the Attention Network Test (ANT), a standard procedure that estimates the
functional state of three neural networks controlling the efficiency of three different attentional behaviors, i.e.,
alerting (achieving and maintaining a state of high sensitivity to incoming stimuli), orienting (ability to select
information from sensory input), and executive attention (mechanisms for resolving conflict among thoughts,
feelings, and actions).
Methods: We evaluated 22 FES patients from 17 to 29 years of age with a recent history of a single psychotic
episode treated only with atypical neuroleptics, and 20 healthy persons matched with FES patients by sex, age, and
educational level as the control group. Attention was estimated using the ANT in which participants indicate
whether a central horizontal arrow is pointing to the left or the right. The central arrow may be preceded by spatial
or temporal cues denoting where and when the arrow will appear, and may be flanked by other arrows (hereafter,
flankers) pointing in the same or the opposite direction.
Results: The efficiency of the alerting, orienting, and executive networks was estimated by measuring how reaction
time was influenced by congruency between temporal, spatial, and flanker cues. We found that the control group
only demonstrated significantly greater attention efficiency than FES patients in the executive attention network.
Conclusions: FES patients are impaired in executive attention but not in alerting or orienting attention, suggesting
that executive attention deficit may be a primary impairment during the progression of the disease.
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Schizophrenia is a mental illness affecting 1% of the
world population and has severe deleterious effects on
quality of life; mainly because symptoms begin at an
early age and full recovery has not been achieved with
current therapies [1]. Schizophrenia is characterized by
multiple cognitive impairments including attention def-
icit [2]. Most psychosocial problems in schizophrenia are
associated with cognitive deficiency [3-6].
The majority of studies on cognition in schizophrenia
involve heterogeneous samples of adults suffering from
chronic schizophrenia with long histories of somatic* Correspondence: mpenag@uc.cl
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reproduction in any medium, provided the ortreatments including electroconvulsive therapy. Thus,
the nature of neurocognitive dysfunction is potentially
confounded by the effects of age, clinical symptoms, ill-
ness duration and severity, and/or treatment. Over the
past 15 to 20 years, however, there has been a growing
interest in the clinical and neurocognitive characteristics
of the early phases of schizophrenia, an approach that
has the potential to minimize many of the interpretive
difficulties associated with studying chronically ill
patients [7].
Attention deficits have been reported in schizophrenia
from the earliest descriptions of the disease [8]. As one
of the earliest clinical manifestations of schizophrenia,
attention impairment may be a primary disorder in the
neuropathology of schizophrenia [9,10]. Most data on at-
tention deficit in schizophrenia have involved chronic
patients and have found that these patients demonstratel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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with the Attention Network Test; ANT). Yet, studies of
chronic schizophrenia provide little information to shed
light on which attention capacity is primarily impaired
and which may explain the first manifestations of the
disease.
Attention is not a single unitary system but a set of
integrated processes that act on all levels of cognitive
processing from sensory entry to motor exit [9,11]. As
early as Bleuler’s (1911) articles, many authors have been
led to consider attentional disorder as a basic manifest-
ation of the development of the illness.
Attention in schizophrenia has been primarily studied
with the Stroop test and the Continuous Performance
Test (CPT). The Stroop test estimates how reaction time
slows when a participant must deal with conflicting in-
formation. In the classic Stroop test, participants need to
say, as fast as possible, the name of the color of words
written in ink of the same or of a different color from
that which is specified by the letters (e.g., the word “blue”
written in green ink). Participants take longer to say the
name of the color when the written words are different
from the ink color. The Stroop test is presented on
printed cards or on a computer screen. In the card ver-
sion of this test, under conditions of conflict, patients
suffering from chronic schizophrenia show slower reac-
tion times and a higher error rate than control partici-
pants. Therefore, schizophrenic patients present an
increase in degree of sensitivity to interference [12].
Studies carried out with the computer version of the
Stroop test have shown that, when compared to healthy
control participants, schizophrenic patients present a
higher error rate in situations ranging from the neutral
to the incongruent or conflicting condition [12]. Deficits
in the execution of the CPT have been detected in
chronic schizophrenia and in adolescent and adult
patients during early stages of the illness, in nonpsychotic
relatives of patients, and in offspring at risk of inheriting
the illness from their schizophrenic parents [13]. The to-
tality of these studies suggest that the sustained attention
deficit, as measured by the CPT, is stable during the
course of the illness, does not improve with antipsychotic
treatment, and has a strong genetic component. CPT
deficits would appear to be specific to schizophrenia;
they are not found in depression and in adolescents that
are at risk of suffering affective illnesses [13].
Current models have shown that attention is not a
unitary function but the result of three different atten-
tional networks, i.e., alerting, orienting, and executive
function [14], that can be independently evaluated using
the ANT [15-17]. Alerting is manifested by achieving
and maintaining the alert state, orienting by the ability
to direct attention to sensory events, and executive at-
tention by efficient control of thoughts, actions, andfeelings. The ANT has been widely validated across a
number of cultures, ages, and morbid entities. Some re-
cent studies exploring attention in chronic schizophrenia
with the ANT have revealed contrasting results: One
study reported impairment in orientation and executive
attention [18], whereas others referred exclusively to a
deficit in executive attention [19-21] or in alerting [22].
Still other studies have produced controversial results,
reporting smaller conflict effect scores in individuals
with chronic schizophrenia measured behaviorally [23]
and by event-related potentials [24]. Finally, another
study observed that positive syndrome patients showed
less efficiency than healthy controls in the orientation
network [25]. The discrepancy reported by these studies
may be due to the heterogeneity of symptoms and syn-
dromes in chronic schizophrenic patients. For example,
the sample described by Gooding et al. [19] consisted of
chronic schizophrenia–spectrum patients including
chronic schizophrenia and schizoaffective disorder.
However, the inconsistency can also be a consequence of
differences in the progression and treatment of the dis-
ease. Studying patients with first-episode schizophrenia
(FES) provides the advantage of being able to control
the different factors described above. A consistent im-
pairment in attention exists in FES [7]; nevertheless, to
the best of our knowledge, attention networks in FES
patients have not been evaluated with the ANT. The
aim of our study was to establish which attentional net-
work is impaired in schizophrenia during early stages of
the disease treated only with one atypical antipsychotic.
Since schizophrenia is highly related to dopamine and
prefrontal dysfunction in its earliest stages, we may ex-
pect that FES patients exhibit exclusive reduction in
executive attention [26,27]. Indeed, in monkeys, alerting
is more influenced by norepinephrine [28] and orienting
by acetylcholine [29-31]. We thus hypothesize that, con-
trary to patients with chronic schizophrenia, FES




Twenty-two FES participants took part in this study.
FES patients were recruited between 2004 and 2009
from Psychiatry Services of Hospital Barros Luco Tru-
deau and Hospital Salvador in Santiago, Chile. The 22
FES patients met the clinical and DSM-IV-TR criteria
for schizophrenia in the Structured Clinical Interview
for DSM-IV Axis I Disorders (SCID-I). Nineteen FES
patients were paranoid, two disorganized, and one cata-
tonic. They were evaluated during a period ranging from
1 to 36 months after clinical diagnosis with no history of
other episodes prior to or after diagnosis. After a psych-
otic episode, FES patients were rated on the Positive and
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Positive Syndrome Scale ranged from 7 to 13 (mean=8.5 ±
2.0) and on the Negative Syndrome Scale ranged from 7
to 28 (mean = 16.8 ± 6.2), corresponding to mild schizo-
phrenia. During the evaluations of our study, FES
patients were clinically stable, receiving a single atypical
antipsychotic medication, i.e., Risperidone in 14 FES
patients (dose: 4.5-9 mg/day), Olanzapine in three FES
patients (dose: 20–30 mg/day), Clozapine in four
FES patients (dose: 125–550 mg/day), and Quetiapine in
one FES patient (dose: 250 mg/day). Computed cerebral
tomography of 20 patients showed no brain abnormal-
ities. Two patients refused to participate. FES patients
showed no significant extrapyramidal symptoms upon
evaluation with the Extrapyramidal Symptom Rating
Scale (ranging from 0 to 10 with a maximum score of
175) and reported no visual or hearing problems. Every
participant verbally confirmed that they correctly
understood the procedure and the tasks. All evaluations
were carried out in the University of Chile, Department
of Psychiatry. Twenty healthy control participants,
matched with FES patients by age, gender, and years of
education, were also included in the study.
For both FES and control participants, exclusion cri-
teria included history of: (a) brain disease other than
schizophrenia, (b) mental retardation, (c) substance
abuse, or (d) electroconvulsive therapy. The study was
approved by the regional ethics committee for biomed-
ical research of the University of Chile, Faculty of
Medicine. Before participating in any evaluation, all par-
ticipants were invited to participate by a psychiatrist
who explained the study’s goal and steps among other
study-related information, and gave a copy of the written
informed consent. All participants signed the written
informed consent before starting the first evaluation.
Procedure
FES participants were evaluated in three consecutive ses-
sions. In the first session, the SCID-I was used to verify
the clinical diagnosis and the PANSS was administered.
In the second session, global cognition was estimated
with the Dementia Rating Scale (DRS) and Raven’s Pro-
gressive Matrices (RPM), two standard scales evaluating
cognitive efficiency in adults. In the third session, FES
participants underwent the ANT.
Participants of the control group were evaluated in only
two sessions. In the first session, the absence of mental
disorder was verified using the SCID-I, then global cogni-
tion was estimated with the DRS and RPM. In the second
session, control participants underwent the ANT. The
DRS and RPM tests were administered to FES and control
groups to corroborate the differences in global cognition
between both groups and to determine their correlation
with the efficiency of attention networks.Cognitive assessments
Global cognition
The DRS global score estimates combined cognitive
functioning with the following components: attention,
initiation-perseveration, construction, conceptualization,
and memory domains [32]. Some DRS items also assess
overall attentional capacity [33], which can be calculated
by adding the scores of the following untimed tasks to
produce what we will refer to as the DRS attention
score: digit span forward and backward, motor response
to single commands, visual scanning, word list reading,
and visual figure matching. The RPM raw score esti-
mates reasoning by asking participants to determine the
missing segment required to complete a larger pattern
from a series of geometric arrangements that become
progressively more difficult to solve [34].
The ANT
The ANT is a standard task described in detail in Fan
et al., 2002 (Figure 1). In the ANT, stimuli are visually
presented on a screen and participants are instructed to
respond, as quickly and accurately as possible, by press-
ing either a left or a right button indicating the direction
of a centered target arrow (pointing leftward or right-
ward), irrespective of flanking and cue clues. Flankers
are lines (neutral condition) or arrows pointing in the
same (congruent condition) or opposite (incongruent
condition) direction as that of the central target arrow.
Cues are asterisks that can be present or absent. When
cues are present, they appear 400 ms before the stimuli
and provide information about where and when the sub-
sequent stimuli will appear. There are four different cue
types: No-cue (i.e., no cues displayed), Center-cue (i.e.,
cue displayed in the center of the screen), Double-cue
(i.e., two horizontally centered cues simultaneously dis-
played, one 1.5 cm above and one 1.5 cm below a central
fixation point), and Spatial-cue (i.e., cue appears in the
same place where the target will subsequently appear).
To estimate performance of the attention networks, the
four cue types and three flanker types generate 12 ex-
perimental conditions: No-cue congruent, No-cue in-
congruent, No-cue neutral, Central-cue congruent,
Central-cue incongruent, Central-cue neutral, Double-
cue congruent, Double-cue incongruent, Double-cue
neutral, Spatial-cue congruent, Spatial-cue incongruent,
and Spatial-cue neutral. The ANT was presented in four
blocks: one full-feedback practice block of 24 trials fol-
lowed by three experimental blocks without feedback of
96 trials each. The 96 trials resulted from the combin-
ation of four cues (No-cue, Central-cue, Double-cue,
and Spatial-cue), three congruency types (Congruent, In-
congruent, and Neutral), two directions (Left and Right),
and two locations (Up and Down) with each combin-
ation presented twice. Trials from different experimental
Figure 1 ANT. a) There are four different cue types: No-cue (i.e., no cues displayed), Center-cue (i.e., cue displayed in the center of the screen),
Double-cue (i.e., two horizontally centered cues simultaneously displayed), and Spatial-cue (i.e., cue appears in the same place where the target
will subsequently appear); b) Flankers are lines (neutral condition) or arrows pointing in the same (congruent condition) or opposite (incongruent
condition) direction as that of the central target arrow; c) Timeline of the trials. (Adapted from “A symbolic model of human attentional networks"
by H. Wang, J. Fan and T.R. Johnson, 2004, Cognitive Systems Research 5, p. 121. Reprinted with permission).
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took 2 minutes while each experimental block lasted
nearly 5 minutes. A small cross served as a central fix-
ation point. Participants were instructed to direct their
gaze toward the fixation point throughout the task. We
computed the mean accuracy and mean reaction time
(RT) of the trials with correct responses for each experi-
mental condition. Then, we estimated the efficiency of
the alert, orientation, and executive attention networks
using a series of RT subtractions between different ex-
perimental conditions: a) Alert network = No-cue RT –
Double-cue RT; b) Orientation network = Center-cue
RT – Spatial-cue RT; and c) Executive network = Incon-
gruent RT – Congruent RT [15].Statistical analysis
Analysis of demographic, clinical, and global cognition data
Gender, age, years of education, and DRS and RPM
scores of FES and control groups were submitted to a
t test for independent samples (alpha = .05; two-tailed).
Moreover, to measure global attention with a clinical
tool, we submitted the DRS subscore estimating atten-
tion in FES and control groups to a one-way ANOVA.ANT analysis
The mean accuracy and RT in each experimental condi-
tion were submitted to two separate repeated-measures
ANOVA with Target direction (Left & Right), Flanker
type (Neutral, Congruent, & Incongruent), and Cue type
(No, Central, Double, & Spatial cues) as within-subjects
factors, and Group (FES & Control) as the between-
subjects factor. The mean efficiency for alert, orientation
and executive attention networks was submitted to a
repeated-measures ANOVA with Network (Alert, Orien-
tation, & Executive) as the within-subjects factor and
Group (FES & Control) as the between-subjects factor.
The Greenhouse-Geisser correction was applied in all
comparisons.Correlations
We estimated the independence of attention networks
by submitting the mean efficiency between all possible
pairs of attention networks in FES and control partici-
pants to a Spearman correlation analysis. Moreover, we
explored the correlation between attention network effi-
ciency and global cognition by evaluating the mean DRS
and RPM scores against the mean efficiency of each
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other Spearman correlation analysis.
Results
Demographic and clinical data
A comparison of demographic and clinical data between
the two groups of participants is illustrated in Table 1.
There were no significant differences between groups
according to gender (9 versus 8 women in the FES and
control groups respectively; t(41)= 0.059, p = .954), age
(t(41)=−1.463, p= .151), or years of education (t(41)= 1.224,
p= .228).
Global cognition
Results on global cognition are described in Table 1.
Global cognition was significantly lower in FES partici-
pants compared to control participants in both the DRS
(t(41) = 5.5, p < .001) and RPM (t(41) = 8.2, p < .001). Con-
sistent with attention deficiency in FES, the mean overall
attentional capacity estimated by the DRS’s attention
subscore was also significantly lower for FES participants
than controls (F(1,36) = 32.7, p < .001).
The ANT
Accuracy
Accuracy results are illustrated in Figure 2. We found a
main effect of Flanker type (F(1, 42) = 24.8, p< .001), a main
effect of Cue type (F(3,109) = 4.8, p< .005), and two signifi-
cant interactions: Flanker type X Group (F(1,42) = 4.7,
p< .03) and Cue type X Flanker type (F(4,171) = 4.1,
p< .003). A post-hoc analysis revealed that: a) The mean
accuracy was significantly lower for the Incongruent con-
dition compared to Congruent (p < .001) and Neutral
(p < .001) conditions; b) The mean accuracy was signifi-
cantly higher for the Spatial-cue condition compared to
the Central-cue (p < .001) and Double-cue (p < .006) con-
ditions; c) FES participants presented a significantly lower
mean accuracy than the control group only in the Incon-
gruent condition (p< .04); and d) only in the IncongruentTable 1 Demographic and clinical data of the FES and contro
FES patients (n=22)
Mean Standard d
Age (years) 21.8 3.5
Education level (years) 12.1 2.4
DRS* 131.7 8.3
RPM* 34.9 11.4
PANSS POSITIVE 8.5 2.0
PANSS NEGATIVE 16.8 6.2
PANSS PSYCHOP. 26.36 5.90
PANSS TOTAL 51.66 11.48
* p< .05.condition was the mean accuracy significantly higher for
Spatial-cue trials compared to Central-cue (p < .002) and
Double-cue (p< .001) trials. No significant main effects or
interactions were observed for Target Direction.
RT
Results on RTs are plotted in Figure 3. We observed a
main effect of Cue type (F(2,94) = 51.7, p < .001), a main
effect of Flanker type (F(1,58) = 119.9, p < .001), and a sig-
nificant interaction of Flanker type X Group (F(1,58) = 4.0,
p < .04). A post-hoc analysis revealed that: a) The mean
RT was significantly higher for the Incongruent condi-
tion than for the Congruent (p < .001) and Neutral
(p < .009) conditions; b) The mean RT was significantly
higher for the No-cue condition than for the Central-
cue (p < .001), Double-cue (p < .001), and Spatial-cue
(p < .001) conditions; and c) FES participants showed a
significantly higher mean RT than the control group
only in the Incongruent condition (p < .007). Neither sig-
nificant main effects nor interactions were observed for
Target Direction.
Efficiency of attention networks
Results on the efficiency of the attention networks
are presented in Figure 4. A main effect of Network
(F(1,55) = 39.0, p < .001) and a significant interaction of
Network X Group (F(1,55) = 4.0, p < .04) were observed.
Post-hoc analysis showed that the variation in the
mean RT was significantly higher for the Executive
network than for the Alert (p < .001) and Orientation
(p < .001) networks. Moreover, the control group
demonstrated significantly greater attention efficiency
than the FES group only in the Executive attention
network (p < .009). Neither significant main effects
nor interactions were observed for Target Direction.
Independence of attention networks
No significant correlations were found between any pair
of attentional networks.l groups
Control group (n=20)









Figure 2 Mean accuracy for each experimental condition and group. We plotted the mean accuracy for each experimental condition for the
FES and control groups. Vertical lines indicate one standard deviation of the mean.
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When we compared the entire sample (i.e., FES and con-
trol participants), the RPM raw score correlated nega-
tively with the efficiency of the Executive network
(Spearman’s rho=−.32, p < .04). However, when we
restricted the comparison to each group, the correlation
was not significant.
Discussion
To the best of our knowledge, our study is the first to
explore the efficiency of alerting, orienting, andFigure 3 Mean reaction time for each experimental condition and gro
FES and control groups. Vertical lines indicate one standard deviation of thexecutive attention in FES patients using the ANT. In
our sample, FES participants were all being treated with
atypical antipsychotics and no other drugs that affect
cognition, constituting a relatively homogenous group of
patients with schizophrenia. Our results showed that
FES participants have impairment in executive attention,
even when clinical manifestations of the disease are con-
trolled by antipsychotic drugs. The efficiency of execu-
tive attention in FES participants was lower than
observed for control participants. In contrast, alerting
and orienting attention were not significantly impairedup. We plotted the mean RT for each experimental condition for the
e mean.
Figure 4 Mean efficiency of the attention networks. The mean efficiency of the alerting, orienting, and executive attention networks for each
group are plotted. Black dots indicate the mean efficiency and vertical bars indicate one standard error of the mean.
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vious studies in chronic patients using the ANT
[18,19,21]. However, studies focusing solely on male
patients [23], classifying by gender [20], using event-
related potentials [24], and concentrating on symptoms
measured by the PANSS [25] did not report specific
impairments in executive attention. This may be
explained by the heterogeneity of symptoms, syndromes,
and treatments in chronic schizophrenic patients, the
level of nicotine that may improve attention in these
patients [35], or the lack of evaluation of global cogni-
tion in some of these studies. Although our study does
not endeavor to propose any causal relationships
between initial executive attention damage and later dif-
ficulty with alerting or orienting, impairments in execu-
tive attention in the early stages of schizophrenia may
play a crucial role in the progression of the disease.
The independence of the three attention networks
evaluated with the ANT has been controversial. Al-
though Fan et al. (2002), did not find significant correla-
tions between the networks in their first report, they did
observe interactions between them [15]. A recent study
involving the analysis of 1,141 healthy persons (from dif-
ferent studies) [36] has shown that the level of correl-
ation between the attention networks is influenced by
experimental manipulations. The above-mentioned study
identifies an interaction between the Cue and Flanker
conditions in all studies, supporting the idea that atten-
tional networks influence each other. In our study, we
also found a significant Cue X Flanker interaction in
both FES and control groups due to the significant im-
provement of performance in incongruent trials when
spatial cues were present. These results did not demon-
strate network-specific effects but allow for thepossibility that initial impairment in executive attention
may influence the functioning of alerting and/or orient-
ing attentional networks in more advanced stages of the
disease.
Similar to previous reports [18,37-40], the impairment
in executive attention cannot be directly attributed to a
global cognition deficiency in our study. Although the
DRS total scores, DRS attention scores, and RPM scores
were significantly lower for FES than for control partici-
pants, they did not significantly correlate to the effi-
ciency of executive attention, accuracy, or RT for any
condition for either group. The poorer performance in
cognitive tasks observed in schizophrenia patients has
also been associated with an overall cognitive slowdown,
secondary to a reduction in motor and information pro-
cessing speed [7,37,39,41], drowsiness, and extrapyram-
idal symptoms induced by drugs [42,43]. Our results
could not be directly attributed to these factors because
FES participants did not exhibit a significant decrease in
RT for alerting and orienting networks, or any extrapyr-
amidal problems.
Executive attention deficits have been described in sev-
eral neuropsychiatric pathologies such as schizophrenia–
spectrum and schizoaffective disorders [19], Alzheimer
disease, 22q11 deletion syndrome, borderline personality
disorder [44], post-traumatic stress disorder [45], obesity
accompanied by severe psychiatric co-morbidity [46],
and attentional deficit disorder [47]. These deficits may
thus underpin a large range of self-regulation disorders
[17]. Self-regulation refers to the ability to monitor and
modulate the cognitive state, emotions, and behaviors to
accomplish goal-directed tasks, and to adapt to specific
cognitive and social demands [48,49]. Our results mesh
well with this proposal in suggesting that early executive
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ficulties in exerting control over thoughts, feelings, and
actions [50], and over some disexecutive behaviors [51].
Further studies with larger samples and applying other
cognitive assessment batteries are necessary to pinpoint
the exact role of executive attention in specific cognitive
problems of FES patients. Our results, however, contrib-
ute with new data that can potentially facilitate a better
understanding of the physiopathology, diagnosis, and re-
habilitation of schizophrenia.
Conclusion
In this study, we observed that FES patients are impaired
in executive attention but not in alerting or orienting at-
tention. Our findings suggest that executive attention
deficit may be a primary impairment during the progres-
sion of the disease.
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